Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen's Adherence
Bibliographic Data
| ID | 15747393 |
|---|---|
| Authors | Constance E George (Texas Neurology, corresponding author) |
| Year | 2019 |
| Volume | 21 |
| Issue | 4 |
| Pages | E317-323 |
| Publication date | 2019-04-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2019.317 |
| PMID | 31012418 |
| OpenAlex | W2926262754 |
| Language | EN |
| References cited | 2 |
This case explores ethical questions about tracking medication adherence in a 16-year-old patient with schizophrenia. Relevant stakeholders are the teen, the parents, and society. How those stakeholders' interests should be considered is explored here in the context of the psychiatrist's professional care management responsibilities and the burdens each stakeholder must bear over the course of the patient's care
Context (archaeology · Pedagogy · Political science · Psychiatry · Public relations · Schizophrenia (object-oriented programming · Stakeholder · Tracking (education · Adolescent and Pediatric Healthcare · Child and Adolescent Psychosocial and Emotional Development · Medicine · Nursing · Pharmaceutical studies and practices · Psychology
| Highly cited | No |
|---|